The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Pediatric pharmacology

Advanced search

The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma. Pediatric pharmacology. 2023;20(2):176-177. (In Russ.)

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?